XHH80HB
Insertion Subcutaneous Tissue and Fascia, Chest to New Technology Group 11 with Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | H Skin, Subcutaneous Tissue, Fascia and Breast |
| Operation | H Insertion |
| Body Part | 8 Subcutaneous Tissue and Fascia, Chest |
| Approach | 0 Open |
| Device | H Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode |
| Qualifier | B New Technology Group 11 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family describes placing a small nonbiological device under the skin, subcutaneous tissue, fascia, or within breast tissue that monitors or supports a bodily function, without replacing any tissue itself. Rather than filling in for missing tissue the way an implant or graft would, the device sits alongside the body's own tissue and does a job the body cannot do well enough on its own, such as tracking a physiological signal or delivering ongoing support to nearby structures. Devices of this kind are typically placed through a small incision and can often be inserted or removed with less disruption than a full reconstructive procedure. Patients considering this type of insertion are usually being offered it as a way to gain closer monitoring of a condition or to support healing and function in the area, and the device is generally understood from the outset to be a tool that works with the body rather than a permanent structural replacement.
Anatomy & Axis Detail
Subcutaneous Tissue and Fascia, Chest
The subcutaneous tissue and fascia of the chest lie beneath the skin overlying the sternum and ribs, providing the anatomic plane where new-technology devices, such as certain implantable monitors or drug-delivery systems, are placed without accessing deeper thoracic structures. Insertion at this site is chosen for its accessibility and the stable, relatively thin tissue layer that allows a device to sit securely while remaining easy to locate for future adjustment or removal. Because the chest wall overlies the heart and lungs, care is taken to keep the device within the subcutaneous and fascial plane rather than penetrating deeper, and its position relative to landmarks such as the sternal notch or costal margin is often documented. Coders should confirm that no device component was left in a body part beyond this superficial tissue layer, since deeper placement would require a different body part value.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode
This value denotes the companion ultrasound transmitter and battery unit that powers and communicates with an endocardiac pacing electrode in certain leadless dual-chamber pacemaker systems, enabling beat-to-beat coordination between separate implanted components. It is distinguished from the pacing electrode itself, which is coded separately, by its role in energy transmission and inter-device communication rather than direct myocardial pacing. Both components work together to achieve atrioventricular synchrony without transvenous leads.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Coders need documentation naming the specific device and its function, since New Technology insertion codes hinge on the qualifier for the exact product or system used, not simply on the fact that something was placed under the skin. The note should make clear the device monitors, assists, or performs a function rather than physically substituting for tissue, and should specify the anatomic layer and site involved. A frequent mistake is defaulting to a generic Insertion code from the standard Medical and Surgical section when the device actually qualifies for a New Technology code, or missing the New Technology code when it is mentioned only in passing in the device log rather than the body of the operative note.